| Offering Information |
| Expected Date | - |
| Proposed Exchange/Ticker |
AMEX: II |
| Security Type |
Common Stock |
| Lead Underwriter |
Maxim Group LLC |
| Days In Registration |
614 |
| Date Filed |
11-Feb-2005 |
| Form Filed | S-B2 |
Fundamentals
(Year Ending December 2007) |
| Industry |
Manufacturing |
| Business Description |
Early-stage medical technology company focusing on designing, manufacturing and commercializing its proprietary electrotherapeutic technologies and products for the non-invasive treatment of a wide array of acute and chronic disorders of soft tissue. |
| Revenue |
- |
| Net Income |
- |
| Shares Outstanding (post-offering) |
9.33M |
| Contact |
- |
| Number of Employees |
- |
|
| Original Filing Information |
| US |
| Shares Filed |
2.5M |
| Secondary Shares Filed | - |
| · As a Percent |
- |
| Primary Shares Filed |
2.5M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
375.0K |
| File Amount |
$17.5M |
| File Price Range |
$8.00 - $6.00 |
| File Mid Price |
$7.00 |
Current Filing Information
(Amended 13-Oct-2006) |
|
US |
|
Shares Filed |
2.5M |
| Secondary Shares Filed |
- |
| · As a Percent |
- |
| Primary Shares Filed |
2.5M |
| · As a Percent |
100.0 |
| Overallotment Shares Filed |
- |
| File Amount |
$17.5M |
| · % Change from Original |
0.0 |
| File Price Range |
$8.00 - $6.00 |
| File Mid Price |
$7.00 |
|
